Mylan on go with generic Malarone

|About: Mylan Inc (MYL)|By:, SA News Editor

Mylan (MYL) launches its generic version of Glaxo's (GSK) Malarone Tablets (atovaquone & proguanil hydrochloride 62.5 mg/25 mg and 250 mg/100 mg) for the prophylaxis and treatment of P. falciparum malaria. According to IMS Health, Malarone generated ~$89M in U.S. sales for the 12-month period ending March 31, 2014.

Mylan has 299 other ANDAs pending FDA approval.